东北制药：获得依非韦伦化学原料药上市申请批准通知书

Group 1 - The core point of the article is that Northeast Pharmaceutical (000597) has received approval from the National Medical Products Administration for the marketing application of the active pharmaceutical ingredient, Defiviren [1] - Defiviren formulation is indicated for the treatment of HIV-1 infection in adults, adolescents, and children in combination with other antiviral medications [1]